12 Health Care Stocks Moving In Wednesday's Intraday Session

Loading...
Loading...

Gainers

  • EyePoint Pharmaceuticals EYPT shares moved upwards by 25.83% to $17.68 during Wednesday's regular session. The current volume of 8.9 million shares is 2187.14% of EyePoint Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $508.6 million.
  • Rockwell Medical RMTI stock increased by 13.46% to $0.55. The current volume of 14.8 million shares is 2093.3% of Rockwell Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $51.2 million. The company's, Q3 earnings came out 2 days ago.
  • Varex Imaging VREX shares moved upwards by 12.76% to $30.27. Varex Imaging's stock is trading at a volume of 900.5K shares as of 12:30 EST. This is 302.16% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion. The company's, Q4 earnings came out yesterday.
  • OptiNose OPTN stock moved upwards by 12.57% to $1.79. Trading volume for OptiNose's stock is 1.7 million as of 12:30 EST. This is 632.15% of its average full-day volume over the last 100 days. The company's market cap stands at $95.4 million. The company's, Q3 earnings came out 2 days ago.
  • Zosano Pharma ZSAN stock rose 12.33% to $0.7. The current volume of 39.9 million shares is 2818.02% of Zosano Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $82.7 million.
  • UpHealth UPH shares increased by 11.97% to $3.46. UpHealth's stock is trading at a volume of 2.1 million shares as of 12:30 EST. This is 117.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $499.1 million.

Losers

  • Eloxx Pharmaceuticals ELOX stock decreased by 25.34% to $0.88 during Wednesday's regular session. Trading volume for Eloxx Pharmaceuticals's stock is 6.0 million as of 12:30 EST. This is 1173.28% of its average full-day volume over the last 100 days. The company's market cap stands at $75.9 million.
  • Second Sight Medical EYES stock decreased by 22.73% to $2.63. Trading volume for Second Sight Medical's stock is 4.1 million as of 12:30 EST. This is 389.23% of its average full-day volume over the last 100 days. The company's market cap stands at $103.8 million. The company's, Q3 earnings came out 3 days ago.
  • Atea Pharmaceuticals AVIR shares fell 22.19% to $8.84. Trading volume for this security as of 12:30 EST is 6.0 million, which is 137.52% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $731.7 million. The company's, Q3 earnings came out 4 days ago.
  • Cassava Sciences SAVA stock fell 21.9% to $48.18. Trading volume for this security as of 12:30 EST is 10.0 million, which is 120.44% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 billion.
  • Cyclo Therapeutics CYTH stock decreased by 21.12% to $5.79. As of 12:30 EST, Cyclo Therapeutics's stock is trading at a volume of 823.8K, which is 1008.87% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.2 million. The company's, Q3 earnings came out 2 days ago.
  • PAVmed PAVM shares decreased by 16.47% to $4.11. As of 12:30 EST, PAVmed's stock is trading at a volume of 7.4 million, which is 334.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $348.3 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...